De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
CAMLINFINE Overzicht aandelen
Camlin Fine Sciences Limited houdt zich samen met haar dochterondernemingen bezig met onderzoek, ontwikkeling, productie en marketing van speciale chemicaliën, ingrediënten en additievenmengsels in India en daarbuiten.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Camlin Fine Sciences Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ₹111.05 |
| 52 Week Hoogtepunt | ₹159.75 |
| 52 Week Laag | ₹79.95 |
| Bèta | 1.13 |
| 11 maand verandering | 6.01% |
| 3 maanden verandering | -0.86% |
| 1 Jaar Verandering | -30.49% |
| 33 jaar verandering | -37.72% |
| 5 jaar verandering | 73.11% |
| Verandering sinds IPO | 28.68% |
Recent nieuws en updates
Recent updates
Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around
Oct 19
Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet
Mar 29Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump
Mar 29Is There An Opportunity With Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 31% Undervaluation?
Sep 02Is It Time To Consider Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Apr 06Rainbows and Unicorns: Camlin Fine Sciences Limited (NSE:CAMLINFINE) Analysts Just Became A Lot More Optimistic
Feb 19Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 17Should You Think About Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE) Now?
Oct 15Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares Could Be 32% Below Their Intrinsic Value Estimate
Jan 15Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Paint A Concerning Picture
Jan 04Why Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Worth Watching
Nov 30Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Oct 05At ₹163, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?
Aug 20Estimating The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jun 30Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Feb 26What Is Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Share Price Doing?
Feb 15Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Popular Amongst Insiders?
Feb 05
Camlin Fine Sciences (NSE:CAMLINFINE) Shareholders Booked A 29% Gain In The Last Year
Jan 26Here's What To Make Of Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Jan 16Don't Ignore The Fact That This Insider Just Sold Some Shares In Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jan 06Should You Be Adding Camlin Fine Sciences (NSE:CAMLINFINE) To Your Watchlist Today?
Jan 04Can Mixed Fundamentals Have A Negative Impact on Camlin Fine Sciences Limited (NSE:CAMLINFINE) Current Share Price Momentum?
Dec 24How Should Investors React To Camlin Fine Sciences' (NSE:CAMLINFINE) CEO Pay?
Dec 13Does Camlin Fine Sciences's (NSE:CAMLINFINE) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 02Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Nov 21Is Now An Opportune Moment To Examine Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Nov 09The Camlin Fine Sciences (NSE:CAMLINFINE) Share Price Is Up 49% And Shareholders Are Holding On
Oct 27What Do The Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Tell Us?
Oct 14Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 29% Price Boost Is Out Of Tune With Earnings
Oct 01Here's Why I Think Camlin Fine Sciences (NSE:CAMLINFINE) Might Deserve Your Attention Today
Sep 30What Kind Of Shareholders Hold The Majority In Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Shares?
Sep 17Read This Before Judging Camlin Fine Sciences Limited's (NSE:CAMLINFINE) ROE
Sep 04Rendement voor aandeelhouders
| CAMLINFINE | IN Chemicals | IN Markt | |
|---|---|---|---|
| 7D | 10.1% | -0.6% | -0.9% |
| 1Y | -30.5% | 23.4% | 39.7% |
Rendement versus industrie: CAMLINFINE presteerde slechter dan de Indian Chemicals -sector, die het afgelopen jaar een rendement van 29.4 % opleverde.
Rendement versus markt: CAMLINFINE presteerde slechter dan Indian Market, dat het afgelopen jaar een rendement van 44.2 % opleverde.
Prijsvolatiliteit
| CAMLINFINE volatility | |
|---|---|
| CAMLINFINE Average Weekly Movement | 5.6% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 3.9% |
Stabiele aandelenkoers: CAMLINFINE heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 7% ) van CAMLINFINE is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1931 | 624 | n/a | www.camlinfs.com |
Camlin Fine Sciences Limited houdt zich, samen met haar dochterondernemingen, bezig met onderzoek, ontwikkeling, productie en marketing van speciale chemicaliën, ingrediënten en additievenmengsels in India en daarbuiten. Het bedrijf biedt houdbaarheidsoplossingen, waaronder antioxidanten zoals Butylated Hydroxy Toluene en Ascorbyl palmitate; en emulgatoren, schimmelremmers, antibacteriële middelen, toxinebinders, pelletbinders, desinfecteermiddelen, energizers, conserveermiddelen, verdikkingsmiddelen en groeibevorderaars, evenals plantaardige antioxidanten, zoals gemengde tocoferolen, groene thee-extract en rozemarijnextract die worden gebruikt om de houdbaarheid te verbeteren onder de merknamen Xtendra en NaSure. Het bedrijf levert ook aroma-ingrediënten, waaronder vanilline en ethylvanilline; gezondheids- en welzijnsproducten; en prestatiechemicaliën, zoals hydrochinon en catechol.
Camlin Fine Sciences Limited Samenvatting
| CAMLINFINE fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ₹18.58b |
| Inkomsten(TTM) | -₹1.42b |
| Inkomsten(TTM) | ₹15.89b |
1.2x
P/S-verhouding-13.1x
Koers/WinstverhoudingIs CAMLINFINE overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| CAMLINFINE resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ₹15.89b |
| Kosten van inkomsten | ₹9.54b |
| Brutowinst | ₹6.35b |
| Overige uitgaven | ₹7.77b |
| Inkomsten | -₹1.42b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -8.49 |
| Brutomarge | 39.96% |
| Nettowinstmarge | -8.95% |
| Schuld/Eigen Vermogen Verhouding | 79.7% |
Hoe presteerde CAMLINFINE op de lange termijn?
Bekijk historische prestaties en vergelijking